Steri M, Orru V, Sidore C, Mulas A, Pitzalis M, Busonero F
Immunology. 2025; 174(4):462-469.
PMID: 39835539
PMC: 11885862.
DOI: 10.1111/imm.13902.
Qin W, Peng C, Yang X, Jiang A, Zhong N, Liu Y
Cell Biol Toxicol. 2024; 41(1):8.
PMID: 39707021
PMC: 11662063.
DOI: 10.1007/s10565-024-09952-8.
Mine K, Nagafuchi S, Akazawa S, Abiru N, Mori H, Kurisaki H
Nat Commun. 2024; 15(1):1337.
PMID: 38351043
PMC: 10864272.
DOI: 10.1038/s41467-024-45573-9.
Zhu L, Li X, Liu D, Bai W, Yang H, Cheng Q
J Cancer Res Clin Oncol. 2023; 149(9):6527-6540.
PMID: 36781502
DOI: 10.1007/s00432-023-04613-5.
Gong X, Ren F
Dis Markers. 2022; 2022:5239033.
PMID: 35711568
PMC: 9197628.
DOI: 10.1155/2022/5239033.
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells.
Nachmias B, Khan D, Voisin V, Mer A, Thomas G, Segev N
Leukemia. 2022; 36(5):1283-1295.
PMID: 35152270
PMC: 9061300.
DOI: 10.1038/s41375-022-01513-4.
Functional characterization of NPM1-TYK2 fusion oncogene.
Kuravi S, Baker R, Mushtaq M, Saadi I, Lin T, Vivian C
NPJ Precis Oncol. 2022; 6(1):3.
PMID: 35042970
PMC: 8766497.
DOI: 10.1038/s41698-021-00246-4.
Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia.
Tavakoli Shirazi P, Eadie L, Heatley S, Page E, Francois M, Hughes T
Cancer Gene Ther. 2022; 29(8-9):1140-1152.
PMID: 35022522
DOI: 10.1038/s41417-021-00421-6.
TYK2 in Cancer Metastases: Genomic and Proteomic Discovery.
Borcherding D, He K, Amin N, Hirbe A
Cancers (Basel). 2021; 13(16).
PMID: 34439323
PMC: 8393599.
DOI: 10.3390/cancers13164171.
Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo.
Jia X, Huang C, Hu Y, Wu Q, Liu F, Nie W
J Exp Clin Cancer Res. 2021; 40(1):105.
PMID: 33731185
PMC: 7972218.
DOI: 10.1186/s13046-021-01903-z.
TYK2 Variants in B-Acute Lymphoblastic Leukaemia.
Turrubiartes-Martinez E, Bodega-Mayor I, Delgado-Wicke P, Molina-Jimenez F, Casique-Aguirre D, Gonzalez-Andrade M
Genes (Basel). 2020; 11(12).
PMID: 33260630
PMC: 7761059.
DOI: 10.3390/genes11121434.
Rare Functional Variants Associated with Antidepressant Remission in Mexican-Americans: Short title: Antidepressant remission and pharmacogenetics in Mexican-Americans.
Wong M, Arcos-Burgos M, Liu S, Licinio A, Yu C, Chin E
J Affect Disord. 2020; 279:491-500.
PMID: 33128939
PMC: 7953425.
DOI: 10.1016/j.jad.2020.10.027.
TYK2 licenses non-canonical inflammasome activation during endotoxemia.
Poelzl A, Lassnig C, Tangermann S, Hromadova D, Reichart U, Gawish R
Cell Death Differ. 2020; 28(2):748-763.
PMID: 32929218
PMC: 7862449.
DOI: 10.1038/s41418-020-00621-x.
Genetic Susceptibility of the Host in Virus-Induced Diabetes.
Mine K, Yoshikai Y, Takahashi H, Mori H, Anzai K, Nagafuchi S
Microorganisms. 2020; 8(8).
PMID: 32727064
PMC: 7464158.
DOI: 10.3390/microorganisms8081133.
Combined p53- and PTEN-deficiency activates expression of mesenchyme homeobox 1 (MEOX1) required for growth of triple-negative breast cancer.
Gasparyan M, Lo M, Jiang H, Lin C, Sun D
J Biol Chem. 2020; 295(34):12188-12202.
PMID: 32467227
PMC: 7443492.
DOI: 10.1074/jbc.RA119.010710.
Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.
Li Z, Rotival M, Patin E, Michel F, Pellegrini S
PLoS One. 2020; 15(1):e0225289.
PMID: 31961910
PMC: 6974145.
DOI: 10.1371/journal.pone.0225289.
TYK2 in Tumor Immunosurveillance.
Karjalainen A, Shoebridge S, Krunic M, Simonovic N, Tebb G, Macho-Maschler S
Cancers (Basel). 2020; 12(1).
PMID: 31936322
PMC: 7017180.
DOI: 10.3390/cancers12010150.
TYK2: An Upstream Kinase of STATs in Cancer.
Woss K, Simonovic N, Strobl B, Macho-Maschler S, Muller M
Cancers (Basel). 2019; 11(11).
PMID: 31694222
PMC: 6896190.
DOI: 10.3390/cancers11111728.
Novel Treatment Targets Based on Insights in the Etiology of Depression: Role of IL-6 Trans-Signaling and Stress-Induced Elevation of Glutamate and ATP.
Kalkman H
Pharmaceuticals (Basel). 2019; 12(3).
PMID: 31362361
PMC: 6789839.
DOI: 10.3390/ph12030113.
NK Cells Require Cell-Extrinsic and -Intrinsic TYK2 for Full Functionality in Tumor Surveillance and Antibacterial Immunity.
Simonovic N, Witalisz-Siepracka A, Meissl K, Lassnig C, Reichart U, Kolbe T
J Immunol. 2019; 202(6):1724-1734.
PMID: 30718299
PMC: 6398083.
DOI: 10.4049/jimmunol.1701649.